ViAqua Therapeutics Ltd.

📍 Haifa, Israel🗓 Founded 2014👥 15 employees💰 Last funded Nov 2023
Biotechnology Research🌐 viaqua-t.com
Website LinkedIn
ViAqua Therapeutics addresses the growing need for effective and affordable health management solutions for aquaculture. ViAqua’s 1st product is a novel oral delivery platform designed to deliver RNA. Co-developed with Skretting (a Nutreco company), RNA induced resistance to White Spot Shrimp Virus is incorporated into and delivered by shrimp-feed.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2014
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Netherlands
2
Frequently asked questions
Who invested in ViAqua Therapeutics Ltd.?
ViAqua Therapeutics Ltd. has 2 investors on record on gritt.io and 2 late-stage investors.
When did ViAqua Therapeutics Ltd. last raise funding?
The most recent investment in ViAqua Therapeutics Ltd. recorded on gritt.io was in November 2023.
When was ViAqua Therapeutics Ltd. founded?
ViAqua Therapeutics Ltd. was founded in 2014.
What industry is ViAqua Therapeutics Ltd. in?
ViAqua Therapeutics Ltd. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ViAqua Therapeutics Ltd. based?
ViAqua Therapeutics Ltd. is headquartered in Haifa, Israel.